Länder Analysen: Schweiz
| 08.10.25 | Givaudan Hold | Jefferies & Company Inc. | |
| 08.10.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 08.10.25 | UBS Buy | Deutsche Bank AG | |
| 08.10.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.10.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 08.10.25 | Givaudan Neutral | UBS AG | |
| 08.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.10.25 | Roche Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 07.10.25 | UBS Outperform | RBC Capital Markets | |
| 07.10.25 | DocMorris Equal Weight | Barclays Capital | |
| 07.10.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 07.10.25 | DocMorris Buy | Jefferies & Company Inc. | |
| 07.10.25 | Matador Secondary Private Equity Kaufen | SMC Research | |
| 06.10.25 | UBS Underweight | Morgan Stanley | |
| 06.10.25 | Richemont Neutral | Goldman Sachs Group Inc. | |
| 06.10.25 | Novartis Buy | Deutsche Bank AG | |
| 03.10.25 | UBS Underweight | Barclays Capital | |
| 02.10.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 30.09.25 | Nestlé Neutral | UBS AG | |
| 30.09.25 | ABB (Asea Brown Boveri) Underweight | Barclays Capital | |
| 30.09.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 30.09.25 | Nestlé Hold | Jefferies & Company Inc. | |
| 29.09.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 29.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.09.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.09.25 | Nestlé Market-Perform | Bernstein Research | |
| 29.09.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 29.09.25 | Richemont Buy | UBS AG | |
| 29.09.25 | Richemont Overweight | Barclays Capital | |
| 29.09.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 26.09.25 | UBS Outperform | RBC Capital Markets | |
| 26.09.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.09.25 | DocMorris Sell | UBS AG | |
| 25.09.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 24.09.25 | Roche Sell | Deutsche Bank AG | |
| 24.09.25 | Givaudan Hold | Deutsche Bank AG | |
| 24.09.25 | Novartis Neutral | UBS AG | |
| 24.09.25 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 23.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 23.09.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 23.09.25 | Roche Buy | UBS AG | |
| 23.09.25 | Novartis Neutral | UBS AG | |
| 22.09.25 | Glencore Overweight | JP Morgan Chase & Co. | |
| 22.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.09.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 19.09.25 | Roche Sell | Deutsche Bank AG | |
| 18.09.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |